Myriad Genetics Stops Work on Alzheimer’s Drug
Tuesday, July 1, 2008 - 12:42
in Health & Medicine
Flurizan, a drug developed by Myriad Genetics to treat Alzheimer’s disease, failed in a closely watched late-stage clinical trial, dealing another blow to efforts to combat the illness.